SOTK
Sono-Tek Corporation3.7000
+0.1000+2.78%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
58.19MP/E (TTM)
37.00Basic EPS (TTM)
0.10Dividend Yield
0%Recent Filings
8-K
Q3 sales hold; margins soar
Sono-Tek reported Q3 FY2026 net sales of $5.0M, down 4% yet marking its seventh straight quarter above $5M, with gross margin surging to 50% from 45% and net income up 24% to $340K. Record $12.3M backlog signals order strength amid medical market gains offsetting policy-hit alternative energy softness. Reiterates modest full-year revenue growth.
10-Q
Q3 FY2026 results
Sono-Tek held sales steady at $5.0M in Q3 FY2026 ended November 30, 2025, down 4% y/y yet marking the seventh straight $5M+ quarter, while gross profit climbed 7% to $2.5M (50% margin, +500bps y/y) on favorable high-ASP system mix and lower warranty costs. Operating income doubled to $319K (6% margin), net income rose 24% to $340K ($0.02 diluted EPS, reconciles to 15.7M shares), driven by medical (+27% y/y) and U.S. strength despite alternative energy softness. Cash from operations dipped to $110K (FCF not disclosed in the 10-Q) amid receivables growth from a key solar client, but liquidity stays rock-solid with $11.7M cash/marketables, zero debt, and $1.4M revolver availability at 7%. Backlog hit record $12.3M. Customer concentration persists.
8-K
Q2 sales flat, income up 24%
Sono-Tek posted Q2 FY26 net sales of $5.163 million, flat year-over-year, but net income jumped 24% to $424 thousand amid 50% gross margins. First-half revenue hit a record $10.30 million, up 1%, with net income rising 35% to $909 thousand, fueled by 150% medical sales growth offsetting clean energy softness. Backlog swelled 50% to $11.21 million. Medical demand surges.
8-K
New exec agreements signed
Sono-Tek terminated prior executive agreements and entered new ones on November 5, 2025, with CEO Harshbarger, Executive Chairman Coccio, CFO Bagley, and COO Cichetti. New deals expand 'Resignation for Good Reason'—now including post-change-of-control resignations up to 18 months out—while retaining two years' salary plus prior two years' bonuses upon qualifying exits. Executives stay at-will. Continuity assured amid control threats.
10-Q
Q2 FY2026 results
Sono-Tek posted steady Q2 FY2026 sales of $5.2M, flat y/y but with gross margin up to 50.2% from 48.7% on favorable product mix and lower warranty costs; H1 sales rose 1% y/y to $10.3M while operating income jumped 73% y/y to $905K from expense cuts. Diluted EPS held at $0.03, matching net income of $424K over 15.7M shares. Cash plus marketable securities stood at $10.6M with no debt and $1.4M revolver availability, despite $1.1M operating cash use from receivables tied to a key solar customer. Backlog hit $11.2M. Customer concentration persists.
IPO
Website
Employees
Sector
Industry
AERG
Applied Energetics, Inc.
1.94-0.01
MKSI
MKS Inc.
156.25-3.06
NDSN
Nordson Corporation
236.37-1.42
NOVT
Novanta Inc.
121.36+1.95
NVEC
NVE Corporation
71.27-0.01
SCND
Scientific Industries, Inc.
0.55+0.01
SODI
Solitron Devices, Inc.
19.51+0.01
SONO
Sonos, Inc.
18.24-0.09
SONX
Sonendo, Inc.
0.20-0.07
UCTT
Ultra Clean Holdings, Inc.
25.11-0.53